Archives
|
Entry
|
Blogger
|
Date
▴
|
Location
|
|
Stopping Alzheimer’s Cold: Satori Raises $22M to Pursue Its Vision
|
Luke Timmerman |
01/08/09 |
Boston
|
|
3Tier Group Gets $10M, Socialmedian Sold for $7.5M, Gates Gives $7M to IDRI, & More Seattle-Area Deals News
|
Gregory T. Huang |
12/23/08 |
Seattle
|
|
Cadence Turns Attention to Marketplace, as IV Pain Reliever Reaches Goals in Clinical Trials
|
Luke Timmerman |
12/18/08 |
San Diego
|
|
Vaccines Force Their Way off Pharma’s Back Burner, as Price Increases Help Fuel New Wave of Innovation
|
Luke Timmerman |
12/12/08 |
Seattle
|
|
Ambrx Aims to Create New Breed of Custom-Built Biotech Drugs
|
Luke Timmerman |
12/08/08 |
San Diego
|
|
Out With the Old Shots, In With the New: Xconomy Forum To Explore Disruptive Changes in Vaccines
|
Luke Timmerman |
12/05/08 |
Seattle
|
|
Optimer Sharpens Up Commercial Game Plan, After “C.Diff” Drug Success
|
Luke Timmerman |
12/05/08 |
San Diego
|
|
Boston Biotechs Seek Scarce Funds Amid Market Famine at Annual Pitch Event
|
Ryan McBride |
12/04/08 |
Boston
|
|
Bruce Carter Exits Stage Left, Targeted Genetics Cuts Payroll, OncoGenex Cancer Drug Prolongs Lives, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
12/04/08 |
Seattle
|
|
The Pros (and Not Many Cons) of Merck’s HPV Vaccine, According to UW’s Laura Koutsky
|
Luke Timmerman |
12/03/08 |
Seattle
|
|
SunEthanol Picks Up $25M, New Name; Infinity Pharma Pairs with Purdue Pharma; In-Q-Tel Taps Two Local Firms, & More Boston-Area Deals News
|
Rebecca Zacks |
11/24/08 |
Boston
|
|
Idera and Merck Extend R&D Deal
|
Ryan McBride |
11/20/08 |
Boston
|
|
Seattle’s Pharma Godfather, Vaccine Impresario Re-Emerges, Accelerator Gets New Investor & More Seattle-Area Life Sciences News
|
Luke Timmerman |
11/20/08 |
Seattle
|
|
Seattle’s Pharma Godfather, Ben Shapiro, Sees Potential Here To Transform Medicine Despite Setbacks
|
Luke Timmerman |
11/17/08 |
Seattle
|
|
Simple DNA Test Spots Deadly MRSA Bacteria; Adnavance Aims To Take It Mainstream
|
Luke Timmerman |
11/10/08 |
San Diego
|
|
Illumina Shows its Stuff to Wall Street, Stock Still Slides
|
Luke Timmerman |
11/07/08 |
San Diego
|
|
Sirtris Shifts Focus From Resveratrol, Merck Shifts People From Seattle to Boston, Epix Shifts Into Cost-Saving Mode, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
10/29/08 |
Boston
|
|
Gov. Gregoire Urges Biotechies to “Stay Focused”; UW Makes its Biotech Business Case, And A Host of Startups Debut
|
Luke Timmerman |
10/28/08 |
Seattle
|
|
Merck Shutdown of Rosetta is Seattle’s Loss, Boston’s Gain As Company Tries to Lure Key Researchers East
|
Luke Timmerman |
10/24/08 |
Seattle
|
|
Merck Bails on Seattle, Gates Foundation Backs Far-Out Ideas, Zymo Drug Shows Promise & More Seattle-Area Life Sciences News
|
Luke Timmerman |
10/23/08 |
Seattle
|
|
Vulcan’s Healey “Disappointed” in Merck Shutdown, But Says Other Tenants May Fill Void
|
Luke Timmerman |
10/22/08 |
Seattle
|
|
Merck Closing Seattle’s Rosetta Research Center, Cutting 300 Jobs
|
Luke Timmerman |
10/22/08 |
Seattle
|
|
Neuroptix Raises $18.5M For Alzheimer’s Diagnostic Test
|
Luke Timmerman |
10/22/08 |
Boston
|
|
Vertex, Ariad, and Infinity Reach Clinical Milestones; FDA Grants Dying Cancer Patient Access to Tysabri; Genzyme Exec Takes Pervasive Helm; & More Boston-Area Life Sciences News
|
Rebecca Zacks |
10/22/08 |
Boston
|
|
Ariad Gets $12.5M From Merck For Beginning Cancer Trial
|
Luke Timmerman |
10/20/08 |
Boston
|
|
Archemix Looks to Hitch Eli Lilly to Aptamer Express in New Deal
|
Ryan McBride |
10/20/08 |
Boston
|
|
Concert Pharmaceuticals, Flush With Well-Timed Venture Round, Aims for Hot Flashes, HIV
|
Luke Timmerman |
10/14/08 |
Boston
|
|
Lilly Patches Up Relationships in Seattle Biotech, Pushes TB Drug Discovery
|
Luke Timmerman |
10/07/08 |
Seattle
|
|
Amgen’s Dmab Cuts Fracture Risk for Osteoporosis Patients, Just What Investors Wanted to See
|
Luke Timmerman |
09/16/08 |
Seattle
|
|
Novartis To Beef Up Vaccine Research in Cambridge
|
Luke Timmerman |
09/12/08 |
Boston
|
|
Page 1 of
2 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2008 Xconomy. All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
